Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Magnetic Resonance in Chemistry : MRC
|
August 7, 2012
Xanthones from the stems of Cratoxylum cochinchinense
Yinghui Duan, Yi Dai, Liuyuan Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
December 23, 2025
Schisandrol B inhibits osteoclastogenesis and mitigates estrogen deficiency-induced bone loss by targeting TRAF6-NOX1 pathway
Yuangang Su, Jiamin Liang, Haoyu Lian, et al.
Magnetic Resonance in Chemistry : MRC
|
October 15, 2013
Four new prenylated flavonoids from the roots of Cudrania tricuspidata
Liuyuan Chen, Yinghui Duan, Chang Li, et al.
Journal of Translational Medicine
|
January 10, 2026
MSDC-0160, a novel clinical-stage mitochondrial pyruvate carrier inhibitor, suppresses osteoclast differentiation and alleviates type 2 diabetes-related bone loss
Chaofeng Wang, Na Hai, Liuyuan Chen, et al.
Theranostics
|
December 11, 2024
Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolism
Liuyuan Chen, Yuangang Su, Chaofeng Wang, et al.
Phytotherapy Research : PTR
|
August 4, 2024
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS
Jian Huang, Dezhi Song, Minglian Xu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Magnetic Resonance in Chemistry : MRC
|
August 7, 2012
Xanthones from the stems of Cratoxylum cochinchinense
Yinghui Duan, Yi Dai, Liuyuan Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
December 23, 2025
Schisandrol B inhibits osteoclastogenesis and mitigates estrogen deficiency-induced bone loss by targeting TRAF6-NOX1 pathway
Yuangang Su, Jiamin Liang, Haoyu Lian, et al.
Magnetic Resonance in Chemistry : MRC
|
October 15, 2013
Four new prenylated flavonoids from the roots of Cudrania tricuspidata
Liuyuan Chen, Yinghui Duan, Chang Li, et al.
Journal of Translational Medicine
|
January 10, 2026
MSDC-0160, a novel clinical-stage mitochondrial pyruvate carrier inhibitor, suppresses osteoclast differentiation and alleviates type 2 diabetes-related bone loss
Chaofeng Wang, Na Hai, Liuyuan Chen, et al.
Theranostics
|
December 11, 2024
Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolism
Liuyuan Chen, Yuangang Su, Chaofeng Wang, et al.
Phytotherapy Research : PTR
|
August 4, 2024
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS
Jian Huang, Dezhi Song, Minglian Xu, et al.
Page
of 1